Radiation recall dermatitis with dabrafenib and trametinib: A case report | Zendy

Mesut Yılmaz | Zendy; Uğur Çelik | Zendy; Seyhan Özakkoyunlu Hasçiçek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Radiation recall dermatitis with dabrafenib and trametinib: A case report

Author(s) -

Mesut Yılmaz,

Uğur Çelik,

Seyhan Özakkoyunlu Hasçiçek

Publication year - 2020

Publication title -

world journal of clinical cases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.368

H-Index - 10

ISSN - 2307-8960

DOI - 10.12998/wjcc.v8.i3.522

Subject(s) - dabrafenib , trametinib , medicine , radiation therapy , recall , dermatology , melanoma , oncology , metastatic melanoma , cancer research , mapk/erk pathway , vemurafenib , linguistics , philosophy , kinase , biology , microbiology and biotechnology

Radiation recall dermatitis has been defined as the "recalling" by skin of previous radiation exposure in response to the administration of certain response-inducing drugs. Although the phenomenon is relatively well known in the medical world, an exact cause has not been documented.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research